Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
43.67
+0.55 (1.28%)
Dec 20, 2024, 4:00 PM EST - Market closed
Korro Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -87.81 | -81.17 | -58.03 | -21.96 |
| Depreciation & Amortization | 3.3 | 3.63 | 2.51 | 1.6 |
| Loss (Gain) From Sale of Assets | 0.07 | 0.07 | - | 0.01 |
| Loss (Gain) From Sale of Investments | -1.16 | -0.08 | -0.15 | 0.02 |
| Stock-Based Compensation | 4.33 | 2.38 | 1.14 | 0.81 |
| Other Operating Activities | 4.37 | 3.61 | 1.51 | -13.47 |
| Change in Accounts Payable | 2.06 | 3.1 | 1.76 | 0.06 |
| Change in Unearned Revenue | - | - | - | -0.69 |
| Change in Other Net Operating Assets | 1.17 | 1.18 | -2.39 | 1.53 |
| Operating Cash Flow | -73.69 | -67.28 | -53.65 | -32.09 |
| Capital Expenditures | -18.11 | -7.84 | -5.21 | -4.45 |
| Sale of Property, Plant & Equipment | - | - | - | 0.01 |
| Investment in Securities | -104.13 | 19 | 16.27 | -35.07 |
| Investing Cash Flow | -122.24 | 11.16 | 11.06 | -39.5 |
| Issuance of Common Stock | 222.63 | 154.55 | 0.06 | 0.03 |
| Other Financing Activities | -9.62 | -12.25 | -0.04 | -0.03 |
| Financing Cash Flow | 213.01 | 187.76 | 0.02 | 115.95 |
| Net Cash Flow | 17.09 | 131.64 | -42.57 | 44.35 |
| Free Cash Flow | -91.79 | -75.12 | -58.86 | -36.54 |
| Free Cash Flow Per Share | -11.62 | -49.12 | -230.65 | -8.22 |
| Cash Income Tax Paid | 0.05 | 0.03 | 0.01 | - |
| Levered Free Cash Flow | -78.02 | -47.69 | -38.2 | - |
| Unlevered Free Cash Flow | -78.02 | -47.69 | -38.2 | - |
| Change in Net Working Capital | 7.7 | -6.97 | -0.24 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.